Epic Research is not viewable using Internet Explorer. Please try accessing it with an alternate browser.
Cosmos Study

Prenatal Depression Correlated with Increased Autism Risk in Children

June 16, 2023
Dual-Team Study
Team A:Dave Little, MD, MSKersten Bartelt, RNJoe Deckert, PhDAlex PiffCameron NavorCaleb Cox
Team B:Nikki Carrico, PharmDJoel Jones, PharmDJoey HaddockTed StampEvan Bryer

Key Findings

  • Babies born to mothers with depression but not prescribed antidepressants are 54.9% more likely to be diagnosed with an autism spectrum disorder (ASD) than those born to mothers without depression. 
  • Antidepressant prescriptions during pregnancy may slightly increase the risk of the child being diagnosed with ASD compared to children born to mothers who did not have an antidepressant prescription. However, this increase may be the result of confounding factors, such as severity of maternal depression. 

Both antidepressant use and autism spectrum disorder (ASD) diagnoses have increased over the last several decades.1,2 The coincidental timing of these increases have led to the hypothesis that antidepressant use during pregnancy may be related to the increase in ASD diagnoses. Some previous studies have shown a possible causal link while others have not.35 

To better understand whether antidepressant use during pregnancy increases the risk of children developing ASD, we first examined the effect of prenatal maternal depression on the development of ASD in 824,549 children whose mother did not have an antidepressant prescription during pregnancy. We compared the rate of ASD between those born to mothers with and without depression, as shown in Figure 1. Children whose mother had depression were 54.9% more likely to be diagnosed with ASD than those whose mother did not have depression during pregnancy. We did not assess how behavioral, environmental, or genetic factors surrounding maternal depression may affect the risk of a child developing ASD as part of this study. 

Figure 1
Autism Rate for Children Born to Mothers with No Antidepressant Prescription
Autism Rate for Children Born to Mothers with No Antidepressant Prescription
Figure 1. Rate of ASD in children born to mothers who did not have an antidepressant prescription during pregnancy stratified by whether the mother had prenatal depression. The difference between the two groups represents the relative risk.

We then examined how the use of antidepressants during pregnancy affects the risk of ASD diagnosis compared to the risk from depression alone, as shown in Figure 2. We studied 50,976 children who were born to mothers who had an active prescription for antidepressants at some point during pregnancy and compared them with the 824,549 children who were born to mothers who did not have an antidepressant prescription during pregnancy. While there is a slightly higher risk for children whose mother was prescribed antidepressants during the second or third trimesters, this increase is not statistically significant. These increases may be caused by confounding factors, such as severity of depression, rather than an effect of the medication.

Figure 2
Autism Risk by Maternal Depression Diagnosis and Antidepressant Prescriptions
Autism Risk by Maternal Depression Diagnosis and Antidepressant Prescriptions
Figure 2. The diagnosis rates and relative risk of developing ASD based on trimester of prenatal antidepressant exposure. Children whose mother had an antidepressant prescription during multiple trimesters are included in all trimesters during which the prescription was active. 

Comparisons between different classes of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs) did not show significant differences in ASD rates. Comparisons between siblings where the mother had an antidepressant prescription during one pregnancy but not the other also showed no significant difference. These findings are consistent with some previous research that showed any effect of antidepressant use during pregnancy on the development of ASD is small.5 


These data come from Cosmos, a HIPAA-defined Limited Data Set of more than 190 million patients from 203 Epic organizations including 1,176 hospitals and more than 25,300 clinics, serving patients in all 50 states and Lebanon. This study was completed by two teams that worked independently, each composed of a clinician and research scientists. The two teams came to similar conclusions. 

References

  1. Pereira VS, Hiroaki-Sato VA. A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta Neuropsychiatrica. 2018;30(6):307-322. doi:10.1017/neu.2017.39 
  2. Keyes KM, Susser E, Cheslack-Postava K, Fountain C, Liu K, Bearman PS. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol. 2012;41(2):495-503. doi:10.1093/ije/dyr193 
  3. Boukhris T, Sheehy O, Mottron L, Bérard A. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatr. 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356 
  4. Sørensen MJ, Grønborg TK, Christensen J, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449-459. Published 2013 Nov 15. doi:10.2147/CLEP.S53009 
  5. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059. Published 2013 Apr 19. doi:10.1136/bmj.f2059